Equity
€123,433 ▲ 17.6%
LABELPHAS has made a profit in every financial year since 2019.
LABELPHAS
Lifetime
7 annual accounts with figures on one time axispeak €63,230 (2024)
€46,198▼ 26.9%
peak €28,095 (2024)
€18,441▼ 34.4%
peak €123,433 (2025)
€123,433▲ 17.6%
€14,050▼ 30.7%
Board2 names since 2018
1 directorSTRENS Alexia
Documentsfilings and deeds
30-04-2026on the last day
2025micro format
Gross margin from €63,230 to €46,198Result from €28,095 to €18,441Equity from €104,992 to €123,433Debts from €20,277 to €14,050
Key points
from the 2025 annual accountsChecked score
95
Excellent
Financially stronger than 60% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.3%▲ +0.2 percentage points vs 04-2025highest value
06-2025: < 0.1%▼ -0.3 percentage points vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: 0.1%▲ +0.1 percentage points vs 04-2026
06-2026: < 0.1%▼ -0.1 percentage points vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 4.09, cash €31,515
Figures for financial year 2025 (filed on 08-05-2026)
Equity €123,433 (89.8% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 60% on liquidity, 36% on profitability and 62% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 30-09-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 26,972 companies had the same profile as LABELPHAS has now. Each dot stands for 68 companies, two years later.
94.9%
were still trading
3.4%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of LABELPHAS itself is lower: < 0.1% within 12 months. It rests on far more data about LABELPHAS than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,972 companies, not a prediction for LABELPHAS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €11,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.09 (2.08 in 2024), above the usual 1.5. Short-term debt is 8.9% and cash 22.9% of total assets. 10.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
on the day
2024
6 days late
2023
13 days early
2022
18 days early
2021
18 days late
2020
on the day
2019
2 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 1 day before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 30 April (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
30-09-2026 year end09-11-2026 today30-04-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0713923562
Company renamed from GS BIOMED CONSULTING to LABELPHAS
STRENS Alexia holds all the shares · General meeting of 18-10-2023 · Gazette deed
Change of role: STRENS, from manager to director
“La prestation de tous types de soins en matière de microbiologie médicale; Toutes activités de coaching…” (deed in French) · General meeting of 24-02-2020 · Gazette deed
Incorporation
Founders: STRENS Alexia and GAUTIER Pascal André Serge · Founding capital of €18,600, 100 shares, €6,200 paid up · Appointment: STRENS Alexia (manager) · published on 29-11-2018 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| LABELPHAS Soignies | €137,483 | €46,198 | 89.8% | - |
| Dr NARDELLA Emily Ixelles | €147,332 | €52,394 | 81.6% | - |
| CNUDDE ARHUBO MEDICAL Les Bons Villers | €60,944 | €62,923 | 49.2% | - |
| DOCTEUR FABIENNE NSANZE Tournai | €82,273 | €38,286 | 84.2% | - |
| DR LAURENCE PRATTE PEDIATRIE Ottignies-Louvain-la-Neuve | €104,544 | €24,429 | 89.2% | - |
| B’YOU by Dr. Shèdy Maasmechelen | €119,852 | €112,330 | 4.5% | - |
| LIPOFINE Brussels | €163,435 | €124,490 | 55.7% | - |
These companies have the same main activity as LABELPHAS: human health activities (NACE 86109). They are comparable in size and age: total assets between €60,900 and €163,000, founded between 2012 and 2021.
Official details
Source: KBO- Status
- Active since 27-11-2018Normal situation
- Activity
- Human health activitiesNACE 86109and 3 others
- Establishment unit
- 2.282.141.9627060 Soignies, since 27-11-2018
- Financial year end
- 30 September
- Peppol
- Reachable since 21-10-2026
Annual accounts to 30-09-2025
- ≈ €140,000estimated
- €137,483▲ 9.8%
- Filing
- Filed on 30-04-2026, on the last day of the filing period
Insights on LABELPHAS
LABELPHAS files the micro format. That format states no turnover. The gross margin rose from €30,861 in 2019 to €46,198 in 2025.
The balance sheet grew most from 2023 to 2025 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about LABELPHAS
- What is the company number of LABELPHAS?
- The company number of LABELPHAS is 0713.923.562. The VAT number is the same number with BE in front: BE 0713.923.562.
- Where is LABELPHAS based?
- The registered office is at Rue du Nouveau Monde 59, 7060 Soignies.Company details
- What does LABELPHAS do?
- According to the KBO register, the main activity is human health activities (NACE 86109).
- What is the legal form of LABELPHAS?
- LABELPHAS is a private limited company (BV).
- When was LABELPHAS founded?
- LABELPHAS was founded on 27-11-2018.
- Is LABELPHAS still active?
- Yes, LABELPHAS is an active enterprise in the KBO register.
- What is the turnover of LABELPHAS?
- The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €46,198 and 47 comparable companies (NACE 86). It probably lies between €100,000 and €200,000. In financial year 2023 turnover was €105,211.Financials
- Is LABELPHAS profitable?
- In financial year 2025, LABELPHAS made a profit of €18,441.
- Where can I find the annual accounts of LABELPHAS?
- LABELPHAS filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LABELPHAS due?
- LABELPHAS must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.